Single-Cell Analysis - Global Strategic Business Report 2026: Capitalize on 20.4% CAGR as Illumina, Thermo Fisher Scientific, Bio-Rad and Agilent Battle for Shares in the $26.1 Billion Market by 2032
Dublin, Nov. 11, 2026 (GLOBE NEWSWIRE) -- "Single-Cell Analysis - Global Strategic Business Report 2026" has been added to ResearchAndMarkets.com's offering.
The global single-cell analysis market was valued at US$7.1 billion in 2025 and is projected to reach US$26.1 billion by 2032, expanding at a compound annual growth rate (CAGR) of 20.4%. Growth is being supported by increasing demand for precision medicine, targeted therapies, biomarker discovery and advanced cellular research across pharmaceutical, biotechnology, academic and clinical settings.
Single-Cell Analysis Market Trends and Growth Drivers
Single-cell analysis is becoming increasingly important in oncology, immunology, neurology, stem cell research and developmental biology. Its ability to characterize cellular heterogeneity is helping researchers identify disease mechanisms, evaluate tumor microenvironments, profile immune responses and develop more precise treatment strategies. Adoption is also increasing in drug discovery, translational research and clinical diagnostics as organizations seek higher-resolution biological insights.
Technological innovation remains a central market driver. High-throughput single-cell RNA sequencing, mass cytometry, advanced flow cytometry and microfluidics-based platforms are enabling researchers to analyze large numbers of individual cells with greater speed and accuracy. Multi-omics platforms that integrate genomics, transcriptomics, proteomics and metabolomics are broadening the scope of single-cell research, while artificial intelligence and machine learning are improving complex data analysis, interpretation and visualization.
Demand is also benefiting from the development of automated, scalable and user-friendly single-cell analysis systems. Continued investment in label-free, non-invasive and high-resolution technologies is expected to improve research productivity and expand adoption among academic laboratories, pharmaceutical companies, biotechnology organizations, hospitals and diagnostic laboratories.
Leading Market Segments and Regional Opportunities
The report analyzes the global single-cell analysis market by component, application, workflow and end use. Components include consumables and instruments. The consumables segment is forecast to reach US$18.3 billion by 2032, advancing at a CAGR of 22%, while the instruments segment is projected to grow at a CAGR of 17% during the analysis period.
Cancer research and immunology are among the leading applications, driven by demand for tumor microenvironment analysis, immune-cell profiling and targeted therapeutic development. Academic and research laboratories remain major adopters, while pharmaceutical and biotechnology companies are expanding their use of single-cell technologies in drug development and biomarker programs.
North America and Europe represent established markets due to advanced research infrastructure, strong biomedical funding and substantial biotechnology activity. The U.S. single-cell analysis market was valued at US$2.1 billion in 2025. China is forecast to reach US$4.4 billion by 2032, growing at a CAGR of 19.2%. Japan, Canada, Germany and the wider Asia-Pacific region also present notable opportunities as healthcare investment and biomedical research capacity increase.
Report Scope and Strategic Value
The market analysis covers the United States, Canada, Japan, China, France, Germany, Italy, the United Kingdom, the rest of Europe, Asia-Pacific and the rest of the world. It provides annual sales analysis and market forecasts in US$ millions from 2025 through 2032, supported by regional, segment and competitive intelligence.
Domain Expert Insights
The report incorporates perspectives from domain experts across industry, enterprise and academia to provide strategic context beyond conventional published research. The report tracks early market signals emerging from expert discussions, corporate activity, conference sessions, keynote presentations, panel discussions, company disclosures, annual reports, institutional publications and other validated sources.
These insights are synthesized to identify where the single-cell analysis market is heading, which forces are influencing its development and which innovations are most likely to affect business strategy. Competitive analysis extends beyond a single global market share figure, recognizing that company positioning and market structure can vary substantially by region. Where relevant, market share analysis is provided for major geographic markets at a level aligned with local competitive dynamics.
Companies Featured
The report includes detailed global single-cell analysis market forecasts, regional assessments, company profiles and one year of complimentary updates, supporting informed strategic planning and investment decisions in this rapidly expanding sector.
Key Attributes
For more information about this report visit https://www.researchandmarkets.com/r/wbox45
About ResearchAndMarkets.com
ResearchAndMarkets.com is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.